10-Jul-2011
While ‘data exclusivity’ clauses will not feature in the India-European Union free trade agreement (FTA), the threat posed by the impending deal to the world’s supply of cheap generic drugs is far from over.
8-Jul-2011
Pharmaceuticals might not have been the most discussed sector before the Korea-European Union Free Trade Agreement came into effect from July 1.
6-Jul-2011
Reuters
Millions of people dependent on life-saving generic drugs to treat HIV/AIDS will die if India stops producing cheap drugs for the disease due to its trade deal with the European Union, the head of UNAIDS warned on Tuesday.
3-Jul-2011
ACT UP-Paris
This morning, in a small town in the region of Gent, Belgium, activists from Act Up-Paris woke up the European Commissioner for Trade in front of his house. They unfurled a banner which said ‘De Gucht, AIDS accomplice’.
27-Jun-2011
Alternet
One of WikiLeaks’ greatest achievements has been to expose the exorbitant amount of influence that multinational corporations have over Washington’s diplomacy.
27-Jun-2011
The Asia Pacific Network of Positive People (APN+) is expressing outrage at ongoing free trade agreement negotiations by the United States with Vietnam and Malaysia that threaten access to medicines for HIV, TB, hepatitis-C as well as other diseases in these countries.
23-Jun-2011
Statement of May 2011 against the increasingly rapid spread of Free Trade Agreements that put the profits of multinational pharmaceutical companies ahead of people’s right to health around the world.
23-Jun-2011
MSF
India formally announced at the UN High
Level Meeting on HIV and AIDS that it will not accept data exclusivity, a
provision harmful to access to affordable medicines, as part of a free trade
agreement currently being negotiated with the European Union.
16-Jun-2011
Infojustice
The TPP chapter may be best seen as a significant step toward the pharmaceutical industry’s ultimate goal, which is a binding international agreement on drug pricing that would restrain the ability of governments to use collective purchasing power to demand prices below “market” levels.
9-Jun-2011
Pharmac is being targeted by US drug companies as trade negotiations continue with the United States.
8-Jun-2011
PharmaBiz
As the global community meets in New York for the United Nations General Assembly High Level Meeting on HIV and AIDS from 8 to 10 June 2011, networks of People living with HIV, health groups and treatment activists from around the world are calling for an immediate moratorium on all Free Trade Agreements (FTAs) and TRIPS-plus measures.
2-Jun-2011
Canadians spend a lot of money (public and private) on health care and much of that is spent on drugs — some $23.4 billion in 2008. Provincial insurance plans are desperately trying to cope, looking to initiatives like the recently passed Ontario law that caps prices of generic drugs at 25 per cent of the brand name equivalent.
30-May-2011
Labour leader Phil Goff says his party would not put government drug buying agency Pharmac on the block to gain a free trade deal with the United States.
29-May-2011
KEI
KEI has received a copy of a May 16, 2011 letter from Karl De Gucht to Andris Piebalgs, which discusses (1) the EU-India FTA, and (2) Relations between IPR and development policies.
23-May-2011
The Green Party is calling on the Government to take Pharmac off the table in Trans Tasman Partnership (TTP) negotiations.
15-May-2011
Some of New Zealand’s most prominent businesspeople are rallying to the support of drug buying body Pharmac as lobbying firm Saunders Unsworth mounts a campaign against the agency ahead of free trade negotiations with the US.
12-May-2011
FDA News
US pharmaceutical industry association the Pharmaceutical Research and Manufacturers of America is calling on the US Trade Representative to include strong intellectual property provisions, such as 12-year data protection for follow-on biologics, in the Trans-Pacific Partnership agreement.
6-May-2011
Nations currently negotiating trade deals with the European Union (EU) have been warned that they must resist European demands which could threaten access to medicines in emerging and developing countries.
5-May-2011
India will not compromise its stand or take a position on intellectual property rights (IPR), especially on pharmaceuticals, beyond its domestic law and agreements as mandated under the aegis of the global trade body—World Trade Organization (WTO).
12-Apr-2011
FSRN
After four years of talks, India and the European Union are narrowing down their differences on a bilateral Free Trade Agreement that critics in India and elsewhere say could have a devastating impact on public health by hampering access to life-saving drugs for millions of people.
